Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13512)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2014 (publication date) through Apr 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vasti C, Hertig CM. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines. World J Cardiol 2014; 6(7): 653-662 [PMID: 25068025 DOI: 10.4330/wjc.v6.i7.653] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i7/653.htm |
| Number | Citing Articles |
| 1 |
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Comprehensive Physiology. 2019; : 905 doi: 10.1002/cphy.c180017
|
| 2 |
Francesca De luliis, Gerardo Salerno, Ludovica Taglieri, Rosina Lanza, Patrizia Cardelli, Susanna Scarpa. Circulating Neuregulin-1 and Galectin-3 can be Prognostic Markers in Breast Cancer. The International Journal of Biological Markers 2017; 32(3): 333 doi: 10.5301/ijbm.5000262
|
| 3 |
Joshua A. Cowgill, Sanjeev A. Francis, Douglas B. Sawyer. Anthracycline and Peripartum Cardiomyopathies. Circulation Research 2019; 124(11): 1633 doi: 10.1161/CIRCRESAHA.119.313577
|
| 4 |
Cassady E. Rupert, Kareen L.K. Coulombe. The Roles of Neuregulin-1 in Cardiac Development, Homeostasis, and Disease. Biomarker Insights 2015; : BMI.S20061 doi: 10.4137/BMI.S20061
|
| 5 |
Joshua H. Decker, Radhakrishna Sura, Paul W. Snyder. Toxicologic Pathology for Non-Pathologists. 2019; : 279 doi: 10.1007/978-1-4939-9777-0_8
|
| 6 |
Miguel Anjos, Marta Fontes-Oliveira, Vera M. Costa, Mário Santos, Rita Ferreira. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. Life Sciences 2021; 280: 119760 doi: 10.1016/j.lfs.2021.119760
|
| 7 |
Tatiana Ammosova, Kareem Washington, Jamie Rotimi, Namita Kumari, Kahli Smith, Xiaomei Niu, Marina Jerebtsova, Sergei Nekhai. Protein Phosphatase-1 Regulates Expression of Neuregulin-1. Biology 2016; 5(4): 49 doi: 10.3390/biology5040049
|
| 8 |
Megan Goins, Katie Lovell, Greyson Keel, Julia Cook, Robert Lust. Novel Pathogenesis and Treatments for Cardiovascular Disease. 2023; doi: 10.5772/intechopen.105040
|
| 9 |
Song Jie, Guo Wenying, Sun Lebo, Vivek Pandey. Dehydroevodiamine Alleviates Doxorubicin‐Induced Cardiomyocyte Injury by Regulating Neuregulin‐1/ErbB Signaling. Cardiovascular Therapeutics 2024; 2024(1) doi: 10.1155/cdr/5538740
|
| 10 |
Yosuke K. Kurokawa, Steven C. George. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening. Advanced Drug Delivery Reviews 2016; 96: 225 doi: 10.1016/j.addr.2015.07.004
|
| 11 |
Toufik Abdul-Rahman, Alden Dunham, Helen Huang, Syed Muhammad Awais Bukhari, Aashna Mehta, Wireko A. Awuah, Deba Ede-Imafidon, Emiliano Cantu-Herrera, Suprateeka Talukder, Amogh Joshi, Deborah W. Sundlof, Rahul Gupta. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics. Current Problems in Cardiology 2023; 48(4): 101591 doi: 10.1016/j.cpcardiol.2023.101591
|
| 12 |
A. Silver, A. Palomo, T.M. Okwuosa. Cardio-Oncology. 2017; : 155 doi: 10.1016/B978-0-12-803547-4.00010-0
|
| 13 |
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Doxorubicin‐Induced Cardiomyopathy in Children. Comprehensive Physiology 2019; 9(3): 905 doi: 10.1002/j.2040-4603.2019.tb00082.x
|
| 14 |
Andrew Geissler, Sergey Ryzhov, Douglas B. Sawyer. Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease. Clinical Science 2020; 134(19): 2623 doi: 10.1042/CS20200230
|
| 15 |
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola, Gabriele D’Uva. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.847012
|
| 16 |
Paul J. Hanson, Al Rohet Hossain, Ye Qiu, Huifang M. Zhang, Guangze Zhao, Cheng Li, Veena Lin, Saheedat Sulaimon, Marli Vlok, Gabriel Fung, Victoria H. Chen, Eric Jan, Bruce M. McManus, David J. Granville, Decheng Yang. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00265
|
| 17 |
Iva Minga, Hena Patel, Tochi M. Okwuosa, Niti R. Aggarwal. Sex Differences in Cardiac Diseases. 2021; : 505 doi: 10.1016/B978-0-12-819369-3.00028-9
|
| 18 |
Ahmed M. Kabel, Samir A. Salama, Almokhtar A. Adwas, Remon S. Estfanous. Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity. Pharmaceuticals 2021; 14(11): 1188 doi: 10.3390/ph14111188
|
| 19 |
Syndi Barish, Kathryn Berg, Jeffrey Drozd, Isabella Berglund-Brown, Labeeqa Khizir, Lauren K. Wasson, Christine E. Seidman, Jonathan G. Seidman, Sidi Chen, Martina Brueckner. The H2Bub1-deposition complex is required for human and mouse cardiogenesis. Development 2023; 150(23) doi: 10.1242/dev.201899
|
| 20 |
Santiago Cerrizuela, Guillermo A. Vega‐Lopez, Manuel J. Aybar. The role of teratogens in neural crest development. Birth Defects Research 2020; 112(8): 584 doi: 10.1002/bdr2.1644
|
| 21 |
Younan Samuel, Aswin Babu, Foteini Karagkouni, Ayden Ismail, Sunyoung Choi, Stergios Boussios. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine. Current Issues in Molecular Biology 2023; 45(10): 8337 doi: 10.3390/cimb45100526
|